Related Experiment Videos
Beta-adrenoceptor antagonism and the hyperthyroid rat heart
1Department of Physiology and Pharmacology, University of Queensland, Australia.
Journal of Cardiovascular Pharmacology
|August 1, 1994
Summary
Beta-adrenoceptor antagonists like atenolol partially reduce hyperthyroidism symptoms in rats, but do not prevent cardiac hypertrophy or hypertension. These drugs offer limited cardiovascular protection against hyperthyroidism.
Area of Science:
- Cardiovascular Physiology
- Endocrinology
- Pharmacology
Background:
- Hyperthyroidism causes significant cardiovascular changes, including tachycardia and hypertension.
- Beta-adrenoceptor antagonists are used to manage hyperthyroid symptoms.
- The specific impact of beta-blockers on hyperthyroidism-induced cardiac alterations requires further elucidation.
Purpose of the Study:
- To investigate the efficacy of atenolol in attenuating cardiac changes associated with hyperthyroidism.
- To assess the effects of atenolol on physiological parameters and cardiac function in a rat model of hyperthyroidism.
Main Methods:
- Rats were induced into a hyperthyroid state using triiodothyronine (T3).
- Hyperthyroid rats were treated with atenolol.
- Physiological parameters, cardiac contractility, and beta-adrenoceptor density were measured.
Main Results:
- T3-induced hyperthyroidism led to increased metabolism, cardiac hypertrophy, tachycardia, and hypertension.
- Atenolol treatment attenuated heart rate, temperature, and oxygen consumption increases.
- Cardiac hypertrophy, hypertension, and altered inotropic responses remained unaffected by atenolol.
Conclusions:
- Beta-adrenoceptor antagonists provide only partial amelioration of hyperthyroidism-induced cardiovascular responses.
- Atenolol did not prevent key cardiovascular risks associated with hyperthyroidism, such as cardiac hypertrophy and hypertension.